In the BioHarmony Drug Report Database

"Preview" Icon

Beclometasone

Beclovent, Beconase, Qnasl, Qvar, Vancenase, Vanceril (beclomethasone dipropionate) is a small molecule pharmaceutical. Beclomethasone dipropionate was first approved as Beclovent on 1982-01-01. It is used to treat allergic rhinitis perennial and inflammation in the USA. It is known to target adhesion G protein-coupled receptor G3. Beconase aq’s patents are valid until 2039-01-25 (FDA).

 

Trade Name

 

Beclovent, Beconase, Qnasl, Qvar, Vancenase, Vanceril
 

Common Name

 

beclomethasone dipropionate
 

ChEMBL ID

 

CHEMBL1200500
 

Indication

 

allergic rhinitis perennial, inflammation
 

Drug Class

 

Image (chem structure or protein)

Beclometasone structure rendering